The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Open accessAbstract
Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is rarely reversible. Dysfunctions in the kidney, retina, cardiovascular system, neurons, and liver represent the common complications of diabetes, which again lack effective therapies that can reverse organ injury. Overall, the molecular mechanisms of how type 2 diabetes develops and leads to irreparable organ damage remain elusive. This review particularly focuses on novel targets that may play role in pathogenesis of type 2 diabetes. Further research on these targets may eventually pave the way to novel therapies for the treatment—or even the prevention—of type 2 diabetes along with its complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Environment dominates over host genetics in shaping human gut microbiota
Rothschild, D., Weissbrod, O., Barkan, E., Kurilshikov, A., Korem, T., Zeevi, D., Costea, P. I., Godneva, A., Kalka, I. N., Bar, N., et al. (2018) · Nature · doi:10.1038/nature25973 · Cited by 2,859
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Population-level analysis of gut microbiome variation
Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., et al. (2016) · Science · doi:10.1126/science.aad3503 · Cited by 2,400
Ahlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335
Einarson, T. R., Acs, A., Ludwig, C., & Panton, U. H. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0728-6 · Cited by 2,312
Role of gut microbiota in type 2 diabetes pathophysiology
Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D. B., Morgun, A., & Shulzhenko, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.051 · Cited by 1,708
Kristensen, S. L., Rørth, R., Jhund, P. S., Docherty, K. F., Sattar, N., Preiss, D., Køber, L., Petrie, M. C., & McMurray, J. J. V. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30249-9 · Cited by 1,663
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationMcGuire, D. K., Shih, W. J., Cosentino, F., Charbonnel, B., Cherney, D. Z. I., Dagogo-Jack, S., Pratley, R., Greenberg, M., Wang, S., Huyck, S., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2020.4511 · Cited by 1,235
Ying, W., Riopel, M., Bandyopadhyay, G., Dong, Y., Birmingham, A., Seo, J. B., Ofrecio, J. M., Wollam, J., Hernandez-Carretero, A., Fu, W., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.035 · Cited by 1,191
Low Wang, C. C., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,155
Hu, H., Tian, M., Ding, C., & Yu, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03083 · Cited by 1,131
Hsu, P. P., Kang, S. A., Rameseder, J., Zhang, Y., Ottina, K. A., Lim, D., Peterson, T. R., Choi, Y., Gray, N. S., Yaffe, M. B., et al. (2011) · Science · doi:10.1126/science.1199498 · Cited by 1,084
CREB and the CRTC co-activators: sensors for hormonal and metabolic signals
Altarejos, J. Y., & Montminy, M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3072 · Cited by 1,040
Stratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019
Copps, K. D., & White, M. F. (2012) · Diabetologia · doi:10.1007/s00125-012-2644-8 · Cited by 1,017
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Bornfeldt, K. E., & Tabas, I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.015 · Cited by 995
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
Feldman, E. L., Nave, K.-A., Jensen, T. S., & Bennett, D. L. H. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.005 · Cited by 915
Neuen, B. L., Young, T., Heerspink, H. J. L., Neal, B., Perkovic, V., Billot, L., Mahaffey, K. W., Charytan, D. M., Wheeler, D. C., Arnott, C., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30256-6 · Cited by 893
Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0355-7 · Cited by 854
Long-term follow-up after tight control of blood pressure in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Neil, H. A. W., & Matthews, D. R. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806359 · Cited by 762
A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart
Nicolás-Ávila, J. A., Lechuga-Vieco, A. V., Esteban-Martínez, L., Sánchez-Díaz, M., Díaz-García, E., Santiago, D. J., Rubio-Ponce, A., Li, J. L., Balachander, A., Quintana, J. A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.031 · Cited by 762
Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Fu, Z., R. Gilbert, E., & Liu, D. (2013) · Current Diabetes Reviews · doi:10.2174/157339913804143225 · Cited by 732
TGF-β/Smad signaling in renal fibrosis
Meng, X.-M., Tang, P. M.-K., Li, J., & Lan, H. Y. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00082 · Cited by 666
Rui, L., Aguirre, V., Kim, J. K., Shulman, G. I., Lee, A., Corbould, A., Dunaif, A., & White, M. F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10934 · Cited by 607
The senescence-associated secretory phenotype and its regulation
Lopes-Paciencia, S., Saint-Germain, E., Rowell, M.-C., Ruiz, A. F., Kalegari, P., & Ferbeyre, G. (2019) · Cytokine · doi:10.1016/j.cyto.2019.01.013 · Cited by 601
Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.
Fu, Z., Gilbert, E. R., & Liu, D. (2013) · PubMed · Cited by 600
Lee, Y. S., Kim, J.-W., Osborne, O., Oh, D. Y., Sasik, R., Schenk, S., Chen, A., Chung, H., Murphy, A., Watkins, S. M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.012 · Cited by 598
Rhee, J., Inoue, Y., Yoon, J. C., Puigserver, P., Fan, M., Gonzalez, F. J., & Spiegelman, B. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730870100 · Cited by 567
Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors
Zelniker, T. A., & Braunwald, E. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.031 · Cited by 566
Gelling, R. W., Du, X. Q., Dichmann, D. S., Rømer, J., Huang, H., Cui, L., Obici, S., Tang, B., Holst, J. J., Fledelius, C., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237106100 · Cited by 563
Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
Mesinovic, J., Zengin, A., De Courten, B., Ebeling, P. R., & Scott, D. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s186600 · Cited by 553
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Gödel, M., Hartleben, B., Herbach, N., Liu, S., Zschiedrich, S., Lu, S., Debreczeni-Mór, A., Lindenmeyer, M. T., Rastaldi, M.-P., Hartleben, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44774 · Cited by 547
Foundations of Immunometabolism and Implications for Metabolic Health and Disease
Hotamisligil, G. S. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.009 · Cited by 505
Bierhaus, A., Fleming, T., Stoyanov, S., Leffler, A., Babes, A., Neacsu, C., Sauer, S. K., Eberhardt, M., Schnölzer, M., Lasitschka, F., et al. (2012) · Nature Medicine · doi:10.1038/nm.2750 · Cited by 495
Self-citationTargeting mitochondria-located circrna scar alleviates nash via reducing mros output
Zhao, Q., Liu, J., Deng, H., Ma, R., Liao, J.-Y., Liang, H., Hu, J., Li, J., Guo, Z., Cai, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.009 · Cited by 469
Acceleration of β Cell Aging Determines Diabetes and Senolysis Improves Disease Outcomes
Aguayo-Mazzucato, C., Andle, J., Lee, T. B., Midha, A., Talemal, L., Chipashvili, V., Hollister-Lock, J., van Deursen, J., Weir, G., & Bonner-Weir, S. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.006 · Cited by 469
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
Chaurasia, B., Tippetts, T. S., Mayoral Monibas, R., Liu, J., Li, Y., Wang, L., Wilkerson, J. L., Sweeney, C. R., Pereira, R. F., Sumida, D. H., et al. (2019) · Science · doi:10.1126/science.aav3722 · Cited by 450
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
Wagner, R., Heni, M., Tabák, A. G., Machann, J., Schick, F., Randrianarisoa, E., Hrabě de Angelis, M., Birkenfeld, A. L., Stefan, N., Peter, A., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-1116-9 · Cited by 415
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Wang, X., Zheng, Z., Caviglia, J. M., Corey, K. E., Herfel, T. M., Cai, B., Masia, R., Chung, R. T., Lefkowitch, J. H., Schwabe, R. F., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.016 · Cited by 413
Tomita, I., Kume, S., Sugahara, S., Osawa, N., Yamahara, K., Yasuda-Yamahara, M., Takeda, N., Chin-Kanasaki, M., Kaneko, T., Mayoux, E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.020 · Cited by 376
Zhang, Y., Castellani, L. W., Sinal, C. J., Gonzalez, F. J., & Edwards, P. A. (2004) · Genes & Development · doi:10.1101/gad.1138104 · Cited by 368
Gut microbiome and its role in obesity and insulin resistance
Lee, C. J., Sears, C. L., & Maruthur, N. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14107 · Cited by 350
Klip, A., McGraw, T. E., & James, D. E. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.008351 · Cited by 344
Lv, W., Booz, G. W., Wang, Y., Fan, F., & Roman, R. J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.016 · Cited by 338
Unraveling the regulation of hepatic gluconeogenesis
Zhang, X., Yang, S., Chen, J., & Su, Z. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00802 · Cited by 314
An AMPK–caspase-6 axis controls liver damage in nonalcoholic steatohepatitis
Zhao, P., Sun, X., Chaggan, C., Liao, Z., in Wong, K., He, F., Singh, S., Loomba, R., Karin, M., Witztum, J. L., et al. (2020) · Science · doi:10.1126/science.aay0542 · Cited by 307
Schwann cell interactions with axons and microvessels in diabetic neuropathy
Gonçalves, N. P., Vægter, C. B., Andersen, H., Østergaard, L., Calcutt, N. A., & Jensen, T. S. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.201 · Cited by 305
Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine
Udler, M. S., McCarthy, M. I., Florez, J. C., & Mahajan, A. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00088 · Cited by 302
Martins, A. R., Nachbar, R. T., Gorjao, R., Vinolo, M. A., Festuccia, W. T., Lambertucci, R. H., Cury-Boaventura, M. F., Silveira, L. R., Curi, R., & Hirabara, S. M. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-30 · Cited by 290
Tuttle, K. R., Brosius, F. C., Adler, S. G., Kretzler, M., Mehta, R. L., Tumlin, J. A., Tanaka, Y., Haneda, M., Liu, J., Silk, M. E., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx377 · Cited by 284
Milestones in the history of diabetes mellitus: The main contributors
Karamanou, M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i1.1 · Cited by 265
Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance
Rhea, E. M., & Banks, W. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00521 · Cited by 263
Garvey, W. T., Van Gaal, L., Leiter, L. A., Vijapurkar, U., List, J., Cuddihy, R., Ren, J., & Davies, M. J. (2018) · Metabolism · doi:10.1016/j.metabol.2018.02.002 · Cited by 261
Yang, F., Chung, A. C. K., Huang, X. R., & Lan, H. Y. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.136531 · Cited by 258
Liu, C., Ge, H.-M., Liu, B.-H., Dong, R., Shan, K., Chen, X., Yao, M.-D., Li, X.-M., Yao, J., Zhou, R.-M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814874116 · Cited by 255
Mechanisms of β-cell dedifferentiation in diabetes: recent findings and future research directions
Bensellam, M., Jonas, J.-C., & Laybutt, D. R. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0516 · Cited by 250
Inflammageing and metaflammation: The yin and yang of type 2 diabetes
Prattichizzo, F., De Nigris, V., Spiga, R., Mancuso, E., La Sala, L., Antonicelli, R., Testa, R., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.003 · Cited by 249
Pericytes, an overlooked player in vascular pathobiology
Ferland-McCollough, D., Slater, S., Richard, J., Reni, C., & Mangialardi, G. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.008 · Cited by 230
Spijkerman, A. M. W., Dekker, J. M., Nijpels, G., Adriaanse, M. C., Kostense, P. J., Ruwaard, D., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2604 · Cited by 229
W, Y., M, R., G, B., Y, D., A, B., J, B. S., J, O., J, W., A, H.-C., W, F., et al. (2018) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.15.11.14 · Cited by 229
Conarello, S. L., Jiang, G., Mu, J., Li, Z., Woods, J., Zycband, E., Ronan, J., Liu, F., Roy, R. S., Zhu, L., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0481-3 · Cited by 224
Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes
Krolewski, A. S., Skupien, J., Rossing, P., & Warram, J. H. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.046 · Cited by 219
Endoplasmic Reticulum Stress in Metabolic Disorders
Ghemrawi, R., Battaglia-Hsu, S.-F., & Arnold, C. (2018) · Cells · doi:10.3390/cells7060063 · Cited by 218
Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism
Fu, Y., Sun, Y., Wang, M., Hou, Y., Huang, W., Zhou, D., Wang, Z., Yang, S., Tang, W., Zhen, J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.019 · Cited by 217
Targeting endoplasmic reticulum stress in insulin resistance
Salvadó, L., Palomer, X., Barroso, E., & Vázquez-Carrera, M. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.007 · Cited by 214
Dong, J., Dong, Y., Dong, Y., Chen, F., Mitch, W. E., & Zhang, L. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.200 · Cited by 212
Tanase, D. M., Gosav, E. M., Neculae, E., Costea, C. F., Ciocoiu, M., Hurjui, L. L., Tarniceriu, C. C., Maranduca, M. A., Lacatusu, C. M., Floria, M., et al. (2020) · Nutrients · doi:10.3390/nu12123719 · Cited by 207
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
Yang, H., & Yang, L. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0316 · Cited by 203
Glucagon Receptor Signaling and Glucagon Resistance
Janah, L., Kjeldsen, S., Galsgaard, K. D., Winther-Sørensen, M., Stojanovska, E., Pedersen, J., Knop, F. K., Holst, J. J., & Wewer Albrechtsen, N. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133314 · Cited by 203
Transforming growth factor-β1 and diabetic nephropathy
Chang, A. S., Hathaway, C. K., Smithies, O., & Kakoki, M. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00502.2015 · Cited by 190
Regulation of Skeletal Muscle Glucose Transport and Glucose Metabolism by Exercise Training
Evans, P. L., McMillin, S. L., Weyrauch, L. A., & Witczak, C. A. (2019) · Nutrients · doi:10.3390/nu11102432 · Cited by 190
Diabetes and Alzheimer's Disease: Mechanisms and Nutritional Aspects
Lee, H. J., Seo, H. I., Cha, H. Y., Yang, Y. J., Kwon, S. H., & Yang, S. J. (2018) · Clinical Nutrition Research · doi:10.7762/cnr.2018.7.4.229 · Cited by 189
Gut microbiota and diabetes: From correlation to causality and mechanism
Li, W.-Z., Stirling, K., Yang, J.-J., & Zhang, L. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i7.293 · Cited by 185
Camporez, J.-P. G., Petersen, M. C., Abudukadier, A., Moreira, G. V., Jurczak, M. J., Friedman, G., Haqq, C. M., Petersen, K. F., & Shulman, G. I. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525795113 · Cited by 184
Ethnicity, type 2 diabetes & migrant Asian Indians.
Abate, N., & Chandalia, M. (2007) · PubMed · Cited by 181
Falkevall, A., Mehlem, A., Palombo, I., Heller Sahlgren, B., Ebarasi, L., He, L., Ytterberg, A. J., Olauson, H., Axelsson, J., Sundelin, B., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.01.004 · Cited by 179
How GPCR Phosphorylation Patterns Orchestrate Arrestin-Mediated Signaling
Latorraca, N. R., Masureel, M., Hollingsworth, S. A., Heydenreich, F. M., Suomivuori, C.-M., Brinton, C., Townshend, R. J. L., Bouvier, M., Kobilka, B. K., & Dror, R. O. (2020) · Cell · doi:10.1016/j.cell.2020.11.014 · Cited by 178
GLP-1/glucagon receptor co-agonism for treatment of obesity
Sánchez-Garrido, M. A., Brandt, S. J., Clemmensen, C., Müller, T. D., DiMarchi, R. D., & Tschöp, M. H. (2017) · Diabetologia · doi:10.1007/s00125-017-4354-8 · Cited by 175
Jiang, Q., Liu, C., Li, C.-P., Xu, S.-S., Yao, M.-D., Ge, H.-M., Sun, Y.-N., Li, X.-M., Zhang, S.-J., Shan, K., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci123353 · Cited by 173
Guzman, C. B., Zhang, X. M., Liu, R., Regev, A., Shankar, S., Garhyan, P., Pillai, S. G., Kazda, C., Chalasani, N., & Hardy, T. A. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12958 · Cited by 172
Leng, W., Ouyang, X., Lei, X., Wu, M., Chen, L., Wu, Q., Deng, W., & Liang, Z. (2016) · Mediators of Inflammation · doi:10.1155/2016/6305735 · Cited by 172
The many secret lives of adipocytes: implications for diabetes
Scherer, P. E. (2018) · Diabetologia · doi:10.1007/s00125-018-4777-x · Cited by 172
The role of inflammation in diabetic eye disease
Mesquida, M., Drawnel, F., & Fauser, S. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00750-7 · Cited by 170
Elevated Levels of the Reactive Metabolite Methylglyoxal Recapitulate Progression of Type 2 Diabetes
Moraru, A., Wiederstein, J., Pfaff, D., Fleming, T., Miller, A. K., Nawroth, P., & Teleman, A. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.003 · Cited by 169
Self-citationTanaka, S., Sugiura, Y., Saito, H., Sugahara, M., Higashijima, Y., Yamaguchi, J., Inagi, R., Suematsu, M., Nangaku, M., & Tanaka, T. (2018) · Kidney International · doi:10.1016/j.kint.2018.04.025 · Cited by 166
Mori, H., Inoki, K., Masutani, K., Wakabayashi, Y., Komai, K., Nakagawa, R., Guan, K.-L., & Yoshimura, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.136 · Cited by 165
Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes
Oral, E. A., Reilly, S. M., Gomez, A. V., Meral, R., Butz, L., Ajluni, N., Chenevert, T. L., Korytnaya, E., Neidert, A. H., Hench, R., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.006 · Cited by 164
Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms
Tonna, S. J., El‐Osta, A., Cooper, M. E., & Tikellis, C. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.55 · Cited by 163
Rohm, M., Zeigerer, A., Machado, J., & Herzig, S. (2019) · EMBO reports · doi:10.15252/embr.201847258 · Cited by 163
Self-citationGlycemic Control in Mice with Targeted Disruption of the Glucagon Receptor Gene
Parker, J. C., Andrews, K. M., Allen, M. R., Stock, J. L., & McNeish, J. D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6265 · Cited by 162
Transforming Growth Factor-Beta1 in Diabetic Kidney Disease
Zhao, L., Zou, Y., & Liu, F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00187 · Cited by 160
Hur, J., Sullivan, K. A., Pande, M., Hong, Y., Sima, A. A. F., Jagadish, H. V., Kretzler, M., & Feldman, E. L. (2011) · Brain · doi:10.1093/brain/awr228 · Cited by 158
Insulin Receptor Associates with Promoters Genome-wide and Regulates Gene Expression
Hancock, M. L., Meyer, R. C., Mistry, M., Khetani, R. S., Wagschal, A., Shin, T., Ho Sui, S. J., Näär, A. M., & Flanagan, J. G. (2019) · Cell · doi:10.1016/j.cell.2019.02.030 · Cited by 158
Dapagliflozin slows the progression of the renal and liver fibrosis associated with type 2 diabetes
Tang, L., Wu, Y., Tian, M., Sjöström, C. D., Johansson, U., Peng, X.-R., Smith, D. M., & Huang, Y. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00086.2017 · Cited by 156
PURIFICATION AND CRYSTALLIZATION OF GLUCAGON
Staub, A., Sinn, L. G., & Behrens, O. K. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70910-1 · Cited by 154
Yoo, T., Pedigo, C. E., Guzman, J., Correa-Medina, M., Wei, C., Villarreal, R., Mitrofanova, A. V., Leclercq, F., Faul, C., Li, J., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111213 · Cited by 152
The β-cell assassin: IAPP cytotoxicity
Raleigh, D. P., Zhang, X., Hastoy, B., & Clark, A. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0105 · Cited by 150
JAK inhibition in the treatment of diabetic kidney disease
Brosius, F. C., Tuttle, K. R., & Kretzler, M. (2016) · Diabetologia · doi:10.1007/s00125-016-4021-5 · Cited by 145
Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
Luo, X., Wu, J., Jing, S., & Yan, L. (2016) · Aging and Disease · doi:10.14336/ad.2015.0702 · Cited by 144
Kubota, N., Kubota, T., Kajiwara, E., Iwamura, T., Kumagai, H., Watanabe, T., Inoue, M., Takamoto, I., Sasako, T., Kumagai, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms12977 · Cited by 143
Methylglyoxal Evokes Pain by Stimulating TRPA1
Andersson, D. A., Gentry, C., Light, E., Vastani, N., Vallortigara, J., Bierhaus, A., Fleming, T. H., & Bevan, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077986 · Cited by 142
Peripheral Disruption of the Grb10 Gene Enhances Insulin Signaling and Sensitivity In Vivo
Wang, L., Balas, B., Christ-Roberts, C. Y., Kim, R. Y., Ramos, F. J., Kikani, C. K., Li, C., Deng, C., Reyna, S. M., Musi, N., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00679-07 · Cited by 141
de Jong, M., van der Worp, H. B., van der Graaf, Y., Visseren, F. L. J., & Westerink, J. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0617-4 · Cited by 141
Cui, A., Fan, H., Zhang, Y., Zhang, Y., Niu, D., Liu, S., Liu, Q., Ma, W., Shen, Z., Shen, L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci66062 · Cited by 140
Selvin, E., Yang, N., Steffes, M. W., Bash, L. D., Klein, R., Wong, T. Y., Astor, B. C., Sharrett, A. R., Brancati, F. L., & Coresh, J. (2010) · Diabetes · doi:10.2337/db10-1198 · Cited by 137
Yan, H., Gu, W., Yang, J., Bi, V., Shen, Y., Lee, E. K., Winters, K. A., Komorowski, R., Zhang, C., Patel, J., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147009 · Cited by 135
Renal Lipid Metabolism and Lipotoxicity in Diabetes
Thongnak, L., Pongchaidecha, A., & Lungkaphin, A. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.11.004 · Cited by 133
Üstünel, B. E., Magnuson, B., Acosta-Jaquez, H. A., Keller, J. A., Feener, E. P., & Fingar, D. C. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05437-11 · Cited by 130
Prattichizzo, F., De Nigris, V., La Sala, L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1810327 · Cited by 129
O-GlcNAcylation of Histone Deacetylase 4 Protects the Diabetic Heart From Failure
Kronlage, M., Dewenter, M., Grosso, J., Fleming, T. H., Oehl, U., Lehmann, L., Falcão‐Pires, I., Leite-Moreira, A. F., Volk, N., Gröne, H., et al. (2019) · Circulation · doi:10.1161/circulationaha.117.031942 · Cited by 129
Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling
Ying, W., Wollam, J., Ofrecio, J. M., Bandyopadhyay, G., El Ouarrat, D., Lee, Y. S., Oh, D. Y., Li, P., Osborn, O., & Olefsky, J. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90350 · Cited by 128
Weber, M. A., Mansfield, T. A., Alessi, F., Iqbal, N., Parikh, S. J., & Ptaszynska, A. (2015) · Blood Pressure · doi:10.3109/08037051.2015.1116258 · Cited by 126
Natarajan, R. D. (2021) · Diabetes · doi:10.2337/dbi20-0030 · Cited by 124
Consitt, L. A., & Clark, B. C. (2018) · The Journal of Frailty & Aging · doi:10.14283/jfa.2017.33 · Cited by 122
Magnetic resonance neurography detects diabetic neuropathy early and with Proximal Predominance
Pham, M., Oikonomou, D., Hornung, B., Weiler, M., Heiland, S., Bäumer, P., Kollmer, J., Nawroth, P. P., & Bendszus, M. (2015) · Annals of Neurology · doi:10.1002/ana.24524 · Cited by 121
Self-citationCaputo, T., Gilardi, F., & Desvergne, B. (2017) · FEBS Letters · doi:10.1002/1873-3468.12742 · Cited by 121
Oberkofler, H., Schraml, E., Krempler, F., & Patsch, W. (2003) · Biochemical Journal · doi:10.1042/bj20021665 · Cited by 119
Riaz, T. A., Junjappa, R. P., Handigund, M., Ferdous, J., Kim, H., & Chae, H. (2020) · Cells · doi:10.3390/cells9051160 · Cited by 118
Thielen, L. A., Chen, J., Gu, J., Moukha‐Chafiq, O., Xu, G., JO, S., Grayson, T. B., Lu, B., Li, P., Augelli‐Szafran, C. E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.002 · Cited by 117
Knockdown of ANT2 reduces adipocyte hypoxia and improves insulin resistance in obesity
Seo, J. B., Riopel, M., Cabrales, P., Huh, J. Y., Bandyopadhyay, G. K., Andreyev, A. Y., Murphy, A. N., Beeman, S. C., Smith, G. I., Klein, S., et al. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0003-x · Cited by 114
Intercellular Transmission of Hepatic ER Stress in Obesity Disrupts Systemic Metabolism
Tirosh, A., Tuncman, G., Calay, E. S., RATHAUS, M., Ron, I., Tirosh, A., Yalçın, A., Lee, Y. G., Livne, R., Ron, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.009 · Cited by 113
Tsantoulas, C., Laínez, S., Wong, S., Mehta, I. S., Vilar, B., & McNaughton, P. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam6072 · Cited by 112
Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes
Kuryłowicz, A., & Koźniewski, K. (2020) · Molecules · doi:10.3390/molecules25092224 · Cited by 112
A Role for Insulin in Diabetic Neuropathy
Grote, C. W., & Wright, D. E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00581 · Cited by 110
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
Mitrofanova, A. V., Mallela, S. K., Ducasa, G. M., Yoo, T., Rosenfeld-Gur, E., Zelnik, I. D., Molina, J., Santos, J. V., Ge, M., Sloan, A. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10584-4 · Cited by 109
Ramadan, J. W., Steiner, S. R., O’Neill, C. M., & Nunemaker, C. S. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.08.005 · Cited by 104
Bodur, Ç., Kazyken, D., Huang, K., Üstünel, B. E., Siroky, K. A., Tooley, A. S., Gonzalez, I. E., Foley, D. H., Acosta-Jaquez, H. A., Barnes, T. M., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696164 · Cited by 104
Identifying Common Genetic Risk Factors of Diabetic Neuropathies
Witzel, I., Jelinek, H. F., Khalaf, K. A., Lee, S., Khandoker, A. H., & AlSafar, H. S. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00088 · Cited by 103
Lü, Q., Wang, W., Zhang, M., Ma, Z., Qiu, X., Shen, M., & Yin, X. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7014 · Cited by 99
Quinn, P. G., & Granner, D. K. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.7.3357 · Cited by 97
Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase
Yoneyama, Y., Inamitsu, T., Chida, K., Iemura, S., Natsume, T., Maeda, T., Hakuno, F., & Takahashi, S. (2018) · iScience · doi:10.1016/j.isci.2018.06.006 · Cited by 97
Neurotrophin Signaling Is Required for Glucose-Induced Insulin Secretion
Houtz, J., Borden, P. M., Ceasrine, A. M., Minichiello, L., & Kuruvilla, R. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.10.003 · Cited by 95
Reducing CXCR4-mediated nociceptor hyperexcitability reverses painful diabetic neuropathy
Jayaraj, N. D., Bhattacharyya, B. J., Belmadani, A. A., Ren, D., Rathwell, C. A., Hackelberg, S., Hopkins, B. E., Gupta, H. R., Miller, R. J., & Menichella, D. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci92117 · Cited by 94
Inceptor counteracts insulin signalling in β-cells to control glycaemia
Ansarullah, M., Jain, C., Far, F. F., Homberg, S., Wißmiller, K., von Hahn, F. G., Raducanu, A., Schirge, S., Sterr, M., Bilekova, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03225-8 · Cited by 93
NOTCH1 signaling induces pathological vascular permeability in diabetic retinopathy
Miloudi, K., Oubaha, M., Ménard, C., Dejda, A., Guber, V., Cagnone, G., Wilson, A. M., Tétreault, N., Mawambo, G., Binet, F., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814711116 · Cited by 92
Beta cell dysfunction in diabetes: the islet microenvironment as an unusual suspect
Almaça, J., Caicedo, A., & Landsman, L. (2020) · Diabetologia · doi:10.1007/s00125-020-05186-5 · Cited by 92
Morgenstern, J., Fleming, T. H., Schumacher, D., Eckstein, V., Freichel, M., Herzig, S., & Nawroth, P. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.760132 · Cited by 90
Self-citationApolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity
Seo, J. A., Kang, M., Yang, W.-M., Hwang, W. M., Kim, S. S., Hong, S. H., Heo, J.-I., Vijyakumar, A., de Moura, L. P., Üner, A. G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15963-w · Cited by 89
Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504
Reddy, M. A., Das, S., Chen, Z., Jin, W. L., Wang, M., Lanting, L. L., & Natarajan, R. D. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306770 · Cited by 86
Intestinal microbial metabolites in human metabolism and type 2 diabetes
Herrema, H., & Niess, J. H. (2020) · Diabetologia · doi:10.1007/s00125-020-05268-4 · Cited by 86
Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy
Wu, J., Li, Y., Chen, A., Hong, C., Zhang, C., Wang, H., Zhou, Y., Li, P., Wang, Y., Mao, L., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201810154 · Cited by 85
Homeostatic nuclear RAGE–ATM interaction is essential for efficient DNA repair
Kumar, V., Fleming, T. H., Terjung, S., Gorzelanny, C., Gebhardt, C., Agrawal, R., Mall, M. A., Ranzinger, J., Zeier, M. G., Madhusudhan, T., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx705 · Cited by 83
Self-citationCompromised DNA repair is responsible for diabetes‐associated fibrosis
Kumar, V., Agrawal, R., Pandey, A., Kopf, S., Höffgen, M., Kaymak, S., Bandapalli, O. R., Gorbunova, V. A., Seluanov, A., Mall, M. A., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019103477 · Cited by 77
Self-citationKrause, C., Geißler, C., Tackenberg, H., Gammal, A. T. E., Wolter, S., Spranger, J., Mann, O., Lehnert, H., & Kirchner, H. (2020) · Diabetologia · doi:10.1007/s00125-020-05212-6 · Cited by 75
Compensatory mechanisms for methylglyoxal detoxification in experimental & clinical diabetes
Schumacher, D., Morgenstern, J., Oguchi, Y., Volk, N., Kopf, S., Groener, J. B., Nawroth, P. P., Fleming, T. H., & Freichel, M. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.09.005 · Cited by 73
Self-citationPharmacologic Blockade of αvβ1 Integrin Ameliorates Renal Failure and Fibrosis In Vivo
Chang, Y., Lau, W. L., Jo, H., Tsujino, K., Gewin, L. S., Reed, N. I., Atakilit, A., Nunes, A. C. F., DeGrado, W. F., & Sheppard, D. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050585 · Cited by 72
Anti-inflammatory effects of empagliflozin in patients with type 2 diabetes and insulin resistance
Hattori, S. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0395-5 · Cited by 72
Proximal Neuropathic Lesions in Distal Symmetric Diabetic Polyneuropathy
Pham, M., Oikonomou, D., Bäumer, P., Bierhaus, A., Heiland, S., Humpert, P. M., Nawroth, P. P., & Bendszus, M. (2011) · Diabetes Care · doi:10.2337/dc10-1491 · Cited by 70
Self-citationKim, Y., Kim, C.-S., Joe, Y., Chung, H. T., Ha, T. Y., & Yu, R. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2017.4108 · Cited by 69
Role of TSC–mTOR pathway in diabetic nephropathy
Inoki, K. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.028 · Cited by 69
Zhou, Y., Dong, B., Kim, K. H., Choi, S., Sun, Z., Wu, N., Wu, Y., Scott, J., & Moore, D. D. (2019) · Hepatology · doi:10.1002/hep.30887 · Cited by 69
The Functional Significance of Shc in Insulin Signaling as a Substrate of the Insulin Receptor.
Sasaoka, T., & Kobayashi, M. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.373 · Cited by 67
Mitochondrial involvement in skeletal muscle insulin resistance: A case of imbalanced bioenergetics
Affourtit, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.07.008 · Cited by 67
Kopf, S., Groener, J. B., Κender, Ζ., Fleming, T., Brune, M., Riedinger, C., Volk, N., Herpel, E., Pesta, D. H., Szendrödi, J., et al. (2018) · Respiration · doi:10.1159/000488909 · Cited by 66
Self-citationInsulin decreases atherosclerosis by inducing endothelin receptor B expression
Park, K., Mima, A., Li, Q., Rask‐Madsen, C., He, P., Mizutani, K., Katagiri, S., Maeda, Y., Wu, I., Khamaisi, M., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86574 · Cited by 65
The combination of loss of glyoxalase1 and obesity results in hyperglycemia
Lodd, E., Wiggenhauser, L. M., Morgenstern, J., Fleming, T. H., Poschet, G., Büttner, M., Tabler, C. T., Wohlfart, D. P., Nawroth, P. P., & Krøll, J. (2019) · JCI Insight · doi:10.1172/jci.insight.126154 · Cited by 61
Self-citationWang, X., Cui, A., Chen, F., Xu, L., Hu, Z., Jiang, K., Shang, L., & Chu, J. (2019) · Small · doi:10.1002/smll.201903106 · Cited by 60
Targeting QKI-7 in vivo restores endothelial cell function in diabetes
Yang, C., Eleftheriadou, M., Kelaini, S., Morrison, T. J., González, M. V., Caines, R., Edwards, N., Yacoub, A., Edgar, K. S., Moez, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17468-y · Cited by 60
Wang, M., Wang, Y., Xie, T., Zhan, P., Zou, J., Nie, X., Shao, J., Zhuang, M., Tan, C., Tan, J., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4755-3 · Cited by 59
β-Cell Telomere Attrition in Diabetes: Inverse Correlation Between HbA1c and Telomere Length
Tamura, Y., Izumiyama‐Shimomura, N., Kimbara, Y., Nakamura, K., Ishikawa, N., Aida, J., Chiba, Y., Mori, S., Arai, T., Aizawa, T., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1222 · Cited by 58
Pancreatic Pericytes Support β-Cell Function in a Tcf7l2-Dependent Manner
Sakhneny, L., Rachi, E., Epshtein, A., Guez, H., Wald-Altman, S., Lisnyansky, M., Khalifa-Malka, L., Hazan, A. T., Baer, D., Priel, A., et al. (2017) · Diabetes · doi:10.2337/db17-0697 · Cited by 56
Promoting Glucose Transporter-4 Vesicle Trafficking along Cytoskeletal Tracks: PAK-Ing Them Out
Tunduguru, R., & Thurmond, D. C. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00329 · Cited by 51
Lin, B., MORRIS, D. W., & CHOU, J. Y. (1998) · DNA and Cell Biology · doi:10.1089/dna.1998.17.967 · Cited by 50
Investigational insulin secretagogues for type 2 diabetes
Scheen, A. J. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1152260 · Cited by 50
Nam, J. S., Cho, M. H., Lee, G. T., Park, J. S., Ahn, C. W., Soo, B., Lim, S. K., Kim, K. R., Ha, H., & Lee, H. C. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.032 · Cited by 49
Fatty acid induced metabolic memory involves alterations in renal histone H3K36me2 and H3K27me3
Kumar, S., Pamulapati, H., & Tikoo, K. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.12.019 · Cited by 46
Chen, T., Li, H., Yin, Y., Zhang, Y., Liu, Z., & Liu, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-15053-w · Cited by 46
Lkb1 suppresses amino acid-driven gluconeogenesis in the liver
Just, P., Charawi, S., Denis, R., Savall, M., Traoré, M., Foretz, M., Bastu, S., Magassa, S., Senni, N., Sohier, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19490-6 · Cited by 45
Schlotterer, A., Kolibabka, M., Lin, J., Acunman, K., Dietrichá, N., Sticht, C., Fleming, T. H., Nawroth, P. P., & Hammes, H. (2018) · The FASEB Journal · doi:10.1096/fj.201801146rr · Cited by 44
Self-citationAngiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential
Whitehead, M., Osborne, A., Widdowson, P. S., Yu‐Wai‐Man, P., & Martin, K. R. G. (2019) · Journal of Diabetes Research · doi:10.1155/2019/5140521 · Cited by 44
Hepatic β-arrestin 2 is essential for maintaining euglycemia
Zhu, L., Rossi, M., Cui, Y., Lee, R. J., Sakamoto, W., Perry, N. A., Urs, N. M., Caron, M. G., Gurevich, V. V., Godlewski, G., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92913 · Cited by 43
Cao, L., Wang, Z.-G., & Wan, W. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00417 · Cited by 40
Bioactive lipids and pathological retinal angiogenesis
Elmasry, K., Ibrahim, A. S., Abdulmoneim, S., & Al‐Shabrawey, M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14507 · Cited by 39
Wu, J., Han, J.-L., Hou, B., Deng, C., Wu, H., & Shen, L. (2016) · Oncology Reports · doi:10.3892/or.2016.4638 · Cited by 38
Lindstrom, S. I., Sigurdardottir, S. L., Zapadka, T. E., Tang, J., Liu, H., Taylor, B. E., Smith, D. G., Lee, C. A., DeAngelis, J., Kern, T. S., et al. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.05.016 · Cited by 37
Control of diabetic hyperglycaemia and insulin resistance through TSC22D4
Ekim Üstünel, B., Friedrich, K., Maida, A., Wang, X., Krones-Herzig, A., Seibert, O., Sommerfeld, A., Jones, A., Sijmonsma, T. P., Sticht, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms13267 · Cited by 36
Self-citationHyperglycemic memory in metabolism and cancer
Lee, C., An, D., & Park, J. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0022 · Cited by 36
Thioesterase-mediated control of cellular calcium homeostasis enables hepatic ER stress
Ersoy, B. A., Maner-Smith, K. M., Li, Y., Alpertunga, I., & Cohen, D. E. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93123 · Cited by 36
Dual Mode of glucagon receptor internalization: Role of PKCα, GRKs and β-arrestins
Krilov, L., Nguyen, A., Miyazaki, T., Unson, C. G., Williams, R., Lee, N. H., Ceryak, S. M., & Bouscarel, B. E. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.10.001 · Cited by 34
Metabolic transcriptional memory
Bheda, P. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.019 · Cited by 34
Absence of IQGAP1 Protein Leads to Insulin Resistance
Chawla, B., Hedman, A. C., Sayedyahossein, S., Erdemir, H. H., Li, Z., & Sacks, D. B. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752642 · Cited by 33
Kolibabka, M., Dietrich, N., Klein, T., & Hammes, H. (2018) · Diabetologia · doi:10.1007/s00125-018-4701-4 · Cited by 30
Aljaibeji, H., Mukhopadhyay, D., Mohammed, A. K., Dhaiban, S., Hachim, M. Y., Elemam, N. M., Sulaiman, N. D., Salehi, A. A., & Taneera, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00735 · Cited by 29
Cited by
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
Antar, S. A., Ashour, N. A., Sharaky, M., Khattab, M., Ashour, N. A., Zaid, R. T., Roh, E. J., Elkamhawy, A., & Al-Karmalawy, A. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115734 · Cited by 622
Specific Nanodrug for Diabetic Chronic Wounds Based on Antioxidase-Mimicking MOF-818 Nanozymes
Chao, D., Dong, Q., Yu, Z., Qi, D., Li, M., Xu, L., Liu, L., Fang, Y., & Dong, S. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c09663 · Cited by 317
Tegegne, B. A., Adugna, A., Yenet, A., Yihunie Belay, W., Yibeltal, Y., Dagne, A., Hibstu Teffera, Z., Amare, G. A., Abebaw, D., Tewabe, H., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1440456 · Cited by 61
“There was a signi fi cant knowledge gap that has to be fi lled regarding the neurological, hepatic, ophthalmic, or renal issues related to DM (39, 40).”
Background
Metadata
- Authors
- Demir, S., Nawroth, P. P., Herzig, S., & Ekim Üstünel, B.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2021-07-28
- Volume
- 8
- Issue
- 18
- Pages
- e2100275-e2100275
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W3183548861
- Cited by
- 525
- References
- 216
- FWCI
- 45.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.